Abbott Launches Digene Insta on the Go – Instant Relief from Acidity, Anytime, Anywhere
Dr. Jejoe Karankumar, Director of Medical Affairs at Abbott, said, 'Acidity can strike without warning – during a hectic workday, while traveling, or even on your daily commutes3,4. This ready-to-use, handy solution delivers rapid relief within seconds and is effective for over two hours1. Backed by the trust of a legacy brand, it blends proven efficacy with unmatched convenience—all in a compact, pocket-friendly format designed for life on the move.' The development of this new format was deeply rooted in consumer insights that revealed a growing demand for fast, discreet, and portable solutions to manage acidity. These insights guided Abbott to reimagine the delivery of relief, resulting in a water-free, single-use sachet that aligns with the spontaneous and mobile nature of modern lifestyles. By listening closely to consumer pain points and preferences, Abbott has created a solution that not only meets but anticipates the needs of today's fast-paced world.
To amplify the launch, Digene has rolled out a high-impact, integrated campaign: 'Acidity Kaheen Bhi Ho, Digene Insta On The Go'. This digital-first initiative spans outdoor activations, retail touchpoints, and online platforms—ensuring visibility where it matters most. The campaign includes engaging films such as the Multiplex Film, the Bus Film, and the Adventure Film.
Digene Insta On The Go is a new addition to the Digene range, India's No.1 antacid brand5, offering consumers another option for managing acidity. Now available at major pharmacies and online platforms across India, Digene Insta On The Go complements Abbott's trusted range of antacid solutions, including Digene Gel and Tablets.
1. Refers to the time taken to bring the pH to 3.5, after the amino acid comes in contact with gastric acid. Improved formula refers to higher strength formula with Higher ANC. An invitro study comparing the Preliminary Antacid Test, Acid Neutralizing Capacity and Acid Neutralizing Potential of two antacid products. URAR. Available at: https://www.ijrar.org/IJRAR24D1385.pdf.
2. Dhawal PP, Barve SS. Preliminary in-vitro evaluation of marketed formulations for antacid activity. Int J Basic Clin Pharmacol. 2019:2319-003.
3. Wisely, R. (2018) Why sleep disorders cause heartburn (and vice versa), Why Sleep Disorders Cause Heartburn (and Vice Versa). Available at: https://www.michiganmedicine.org/health-lab/why-sleep-disorders-cause-heartburn-and-vice-versa 4. Heartburn: Causes, symptoms, and treatment (no date) WebMD. Available at: https://www.webmd.com/heartburn-gerd/understanding-heartburn-basics 5. IQVIA Data April 2025 About Abbott Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 114,000 colleagues serve people in more than 160 countries. In India, Abbott was established in 1910 and is one of the country's oldest and most admired healthcare companies. With more than 12,000 employees in the country, Abbott is helping to meet the healthcare needs of consumers, patients, and doctors throughout urban and rural India.
Connect with us at www.abbott.com and www.abbott.in, and on Facebook and India Facebook, LinkedIn, Instagram, X and YouTube.
To View the Image, Click on the Link Below: Digene Insta On The Go (Disclaimer: The above press release comes to you under an arrangement with Business Wire India and PTI takes no editorial responsibility for the same.).
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
an hour ago
- Indian Express
PCMC inspects over 5.4 lakh homes to tackle Dengue and Malaria spread
With the ongoing monsoon, the Pimpri-Chinchwad Municipal Corporation (PCMC) on Monday said it intensified its efforts to prevent the spread of vector-borne diseases such as dengue and malaria. In a large-scale campaign spanning across all eight zones, the civic body has inspected over 5.43 lakh homes and nearly 29 lakh water containers in search of mosquito breeding sites. The drive also covered more than 1,200 scrap yards and over 1,600 construction sites. So far, breeding-friendly conditions were found in the surroundings of 9,680 houses and in over 10,548 water containers. Notices have been issued at 3,431 locations, and penalties have been imposed on 624 households and commercial establishments resulting in the collection of Rs 22.24 lakh in fines, health officials said. Under the guidance of Municipal Commissioner Shekhar Singh, Additional Commissioner Vijaykumar Khorate, and Deputy Commissioner Sachin Pawar, the PCMC health department has adopted a multipronged strategy. This includes not only identifying and eliminating mosquito breeding grounds but also increasing public awareness and taking punitive action wherever necessary, the civic administration said. The campaign involves regular insecticide spraying, household visits by health workers, and the distribution of information pamphlets. In addition, the corporation is running awareness programs in schools and conducting cleanliness drives in public spaces and high-risk areas, officials said. The civic body has appealed to residents to actively support the campaign by keeping their surroundings clean, especially during the rainy season. Citizens are advised to clean water storage containers every week, keep them covered at all times, and observe one 'dry day' each week to prevent mosquito breeding. Municipal Commissioner Shekhar Singh said, 'PCMC is adopting a comprehensive approach to combat dengue and malaria—through larval source elimination, rigorous inspections, and strong awareness campaigns. We urge citizens to actively participate by keeping their surroundings clean and supporting this city-wide effort.' Deputy Commissioner Sachin Pawar added, 'We are reviewing the ward-wise implementation of all anti-mosquito measures. Public support is crucial—every household must observe one dry day each week to prevent mosquito breeding.'
Time of India
2 hours ago
- Time of India
Govt hospital near Tirupur awaiting inauguration despite completion a year ago
Tirupur: A 100-bed govt hospital constructed at a cost of Rs 47.56 crore at 15 Velampalayam in Tirupur district is yet to be inaugurated even though it was complete a year ago. Built with funding from the Japan International Cooperation Agency (JICA), the three-storey hospital features a range of modern medical amenities. "The hospital, initially planned with an 86-bed capacity, was later upgraded to 100 beds to meet the increasing healthcare demands of workers from various districts and states working in Tirupur. Notably, 44 staff members, including eight doctors and 20 nurses, are already appointed to manage the new facility," said Niruban Sakkaravarthi, district joint secretary of the Democratic Youth Federation of India (DYFI). "Construction began in 2021 and was completed a year ago. It was initially scheduled to be inaugurated in October last year. However, it still remains unopened. This hospital will serve residents of Avinashi and the northern parts of Tirupur. Currently, people from these areas have to travel to the Tirupur Govt Medical College Hospital for treatment. For better access to healthcare, the hospital should be opened without further delay," he said. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Beyond Text Generation: An AI Tool That Helps You Write Better Grammarly Install Now Undo A health department official said chief minister M K Stalin planned to inaugurate the hospital during his visit to Tirupur on Wednesday. However, the event was postponed. 'The CM is expected to inaugurate the facility soon,' the official added.
Economic Times
4 hours ago
- Economic Times
Heart pill sales explode 50% in 5 years: What's fueling India's cardiac crisis?
Why are more people taking heart medicines? Live Events What types of medicines are selling more? Statins lower cholesterol Anti-hypertensives reduce blood pressure Anti-anginals help with chest pain by improving blood flow Celebrity deaths and rising concern (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel The rise in heart disease cases across India is now showing up clearly in pharmacy counters. Sales of cardiac medicines have gone up by over 50% in just five years, according to a recent Pharmarack report quoted by June 2021 to June 2025, sales grew from Rs 1,761 crore to Rs 2,645 crore, with a steady yearly growth of 10.7%. These figures come from 17 major Indian pharmaceutical companies that account for more than half of the say there are many reasons behind this increase. First, there is better awareness about heart diseases. Also, more people are getting diagnosed thanks to improved access to health checks. New rules have also changed how hypertension is measured.'Earlier, a reading of 130-140 was considered high. Now, even above 120 is taken seriously,' said Dr Suraj Nagre of JJ population is also ageing. 'As people live longer, heart problems become more common,' said senior cardiologist Dr Akshay medicines today go beyond just lowering cholesterol. There is a growing demand for drugs that treat heart failure, irregular heart rhythms, and chest pain. 'Many of these medicines work together,' explained Dr Ramakanta example:The recent deaths of celebrities and young fitness lovers due to heart attacks have made many people more cautious. Dr Charan Lanjewar from KEM Hospital said that in most cardiac arrest cases, 'there isn't a single cause. It's usually a mix of lifestyle, stress and poor habits.'Government data shows that 63% of all deaths in India are from non-communicable diseases (NCDs), and 27% of those are linked to heart from TOI
